Status:
COMPLETED
Effect of Mannitol on Postreperfusion Syndrome During Living Donor Liver Transplant
Lead Sponsor:
Ain Shams University
Conditions:
Liver Transplant Disorder
Eligibility:
All Genders
16+ years
Phase:
EARLY_PHASE1
Brief Summary
Postreperfusion syndrome during living liver transplants remains a serious concern for transplant anesthesiologists. This syndrome is responsible for decreases in systemic blood pressure, systemic vas...
Eligibility Criteria
Inclusion
- patients with end-stage liver disease who will undergo living donor transplantation.
Exclusion
- Patients with a history of portopulmonary hypertension.
- Hepatopulmonary syndrome.
- Cirrhotic cardiomyopathy.
- Hepatorenal syndrome types 1 and 2.
Key Trial Info
Start Date :
April 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05277623
Start Date
April 4 2022
End Date
December 10 2022
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medicine Ain Shams University
Cairo, Egypt